Pfizer recalls some batches of blood pressure drug over carcinogen presence

(Reuters) – Pfizer mentioned on Friday it was voluntarily recalling 5 batches of its Accupril blood strain tablets after discovering elevated ranges of a possible cancer-causing agent within the drugs.

The drugmaker mentioned it was not conscious of any studies of antagonistic occasions associated to the recalled batches, which had been distributed in the USA and Puerto Rico from December 2019 to April 2022.

Pfizer Canada additionally recalled all a lot of three doses of Accupril on Thursday after discovering the identical impurity to be above acceptable ranges.

Pfizer mentioned there was no fast threat to sufferers taking this remedy, by which the agent, a nitrosamine, was discovered.

Nitrosamines are frequent in water and meals however publicity above acceptable ranges over lengthy intervals of time might enhance the danger of most cancers.

Pfizer final month additionally recalled some batches of one other blood strain drug Accuretic and two licensed cheaper variations because of the presence of the potential carcinogen.

(Reporting by Amruta Khandekar; Enhancing by Krishna Chandra Eluri)